Authors

• Min Dong (ORCID: https://orcid.org/0000-0003-0112-2942)
• Tao Shi (ORCID: https://orcid.org/0000-0002-4945-6979)
• Liye Zhong
• Yang Liang
• Qi Liang
• Zhiqiang Sun
• Hongyu Zhang (ORCID: https://orcid.org/0000-0002-1758-4474)
• Lin Luo (ORCID: https://orcid.org/0000-0003-3361-2751)
• Yongzhong Su
• Wei Y
• Hongling Peng (ORCID: https://orcid.org/0000-0003-2770-5150)
• Xiaoqin Chen
• Jihao Zhou
• Zhenqian Huang
• Xiuju Wang
• Hui Zhou
• Yuyang Tian
• Ru Feng
• Zhongjun Xia
• Xin Du
• Weida Wang
• Guoyu Hu
• Mei Lan
• Yun Wang
• Jun Luo
• Rober Peter Gale

Institutions

• Central South University (CN)
• Sun Yat-sen University (CN)
• Shantou University (CN)
• Sun Yat-sen Memorial Hospital (CN)
• First Affiliated Hospital of Guangzhou Medical University (CN)
• Nanfang Hospital (CN)
• ShenZhen People’s Hospital (CN)
• First Affiliated Hospital of Shantou University Medical College (CN)
• Hunan Cancer Hospital (CN)
• The People's Hospital of Guangxi Zhuang Autonomous Region (CN)
• First Affiliated Hospital of GuangXi Medical University (CN)
• Hainan General Hospital (CN)
• Peking University Shenzhen Hospital (CN)
• Zhuzhou Central Hospital (CN)
• Southern Medical University Shenzhen Hospital (CN)
• Sun Yat-sen University Cancer Center (CN)
• Second Xiangya Hospital of Central South University (CN)
• Hainan Medical College Hospital (CN)
• First Affiliated Hospital of Jinan University (CN)
• Shenzhen Second People's Hospital (CN)
• Imperial College London (GB)
• Southern Medical University (CN)
• Hainan Medical University (CN)
• Guangzhou Medical University (CN)

Publication Details

Journal

Annals of Hematology

Published

2026-02-05

DOI

https://doi.org/10.1007/s00277-026-06808-5

Primary Topic

Multiple Myeloma Research and Treatments

Type

article

Field-Weighted Citation Impact

0.00

Funders

• Beijing Xisike Clinical Oncology Research Foundation